| Diagnosis of multiple sclerosis: progress and challenges WJ Brownlee, TA Hardy, F Fazekas, DH Miller The Lancet 389 (10076), 1336-1346, 2017 | 833 | 2017 |
| Clinical course, therapeutic responses and outcomes in relapsing MOG-antibody associated demyelination DRC Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC ... Journal of Neurol Neurosurg Psychiatry, jnnp-2017-316880, 2017 | 494* | 2017 |
| C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy A Richards, AMJM Van Den Maagdenberg, JC Jen, D Kavanagh, ... Nature genetics 39 (9), 1068-1070, 2007 | 442 | 2007 |
| Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis S Ramanathan, K Prelog, EH Barnes, EM Tantsis, SW Reddel, ... Multiple Sclerosis Journal 22 (4), 470-482, 2016 | 331 | 2016 |
| Tumefactive demyelination: an approach to diagnosis and management TA Hardy, J Chataway Journal of Neurology, Neurosurgery & Psychiatry 84 (9), 1047-1053, 2013 | 176 | 2013 |
| Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations AH Stam, PH Kothari, A Shaikh, A Gschwendter, JC Jen, S Hodgkinson, ... Brain 139 (11), 2909-2922, 2016 | 151 | 2016 |
| Atypical inflammatory demyelinating syndromes of the CNS TA Hardy, SW Reddel, MH Barnett, J Palace, CF Lucchinetti, ... The Lancet Neurology 15 (9), 967-981, 2016 | 151 | 2016 |
| Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy S Ramanathan, D Langguth, TA Hardy, N Garg, C Bundell, ... Neuroimmunology & Neuroinflammation 2 (3), e96, 2015 | 131 | 2015 |
| Baló's concentric sclerosis TA Hardy, DH Miller The Lancet Neurology 13 (7), 740-746, 2014 | 115 | 2014 |
| CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome CC Gross, C Meyer, U Bhatia, L Yshii, I Kleffner, J Bauer, AR Tröscher, ... Nature communications 10 (1), 5779, 2019 | 105 | 2019 |
| Guillain-Barré syndrome: modern theories of etiology TA Hardy, S Blum, PA McCombe, SW Reddel Current allergy and asthma reports 11, 197-204, 2011 | 92 | 2011 |
| Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions MA Smith‐White, TA Hardy, JA Brock, EK Potter British journal of pharmacology 132 (4), 861-868, 2001 | 87 | 2001 |
| The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases N Garg, SW Reddel, DH Miller, J Chataway, DS Riminton, Y Barnett, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (12), 1374-1382, 2015 | 77 | 2015 |
| Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination Tea Acta Neuropathol Commun 7 (1), 145, 2019 | 76 | 2019 |
| The evolution of “No Evidence of Disease Activity” in multiple sclerosis G Lu, HN Beadnall, J Barton, TA Hardy, C Wang, MH Barnett Multiple sclerosis and related disorders 20, 231-238, 2018 | 75 | 2018 |
| Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years MSBS Group Neurology, 2021 | 73 | 2021 |
| Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders S Rinaldi, A Davies, J Fehmi, HN Beadnall, J Wang, TA Hardy, ... Neurology: Neuroimmunology & Neuroinflammation 8 (1), e924, 2020 | 73 | 2020 |
| Long-term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD PSJ Wingerchuk DM, Fujihara, K, Palace, J, Berthele A, Levy M, Kim HJ ... Annals of Neurology, 2021 | 70 | 2021 |
| Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment TA Hardy, B O'Brien, N Gerbis, MH Barnett, SW Reddel, J Brewer, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (5), 582-584, 2015 | 64 | 2015 |
| Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló’s concentric sclerosis TA Hardy, WO Tobin, CF Lucchinetti Multiple Sclerosis Journal 22 (8), 986-992, 2016 | 59 | 2016 |
Michael BarnettThe University of Sydney / Brain and Mind CentreVerified email at sydney.edu.au
